FDA NDC Directory · JSON-LD · Markdown
NDC 0942-9603 · HUMAN PRESCRIPTION DRUG · SOLUTION
| Generic name | Solucion aditiva para plaquetas 3 |
|---|---|
| Labeler / Manufacturer | Fenwal, Inc. |
| Marketing category | New Drug Application (innovator) · App BN080041 |
| Dosage form / route | SOLUTION · INTRAVENOUS |
| Active ingredients | SODIUM ACETATE (442 mg/100mL) SODIUM CHLORIDE (452 mg/100mL) SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM (305 mg/100mL) SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE (93 mg/100mL) TRISODIUM CITRATE DIHYDRATE (318 mg/100mL) |
| Marketing started | 20121025 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).